Congratulations Centre researcher, Dr Zeyad Nassar from the Prostate Cancer Research Group at SAHMRI on being awarded a research grant from Cure Cancer Australia through the 2018 Cancer Australia funding round.
Zeyad was one of 21 early-career cancer researchers be funded in 2019, and one of 8 to be fully supported by the Can Too Foundation, Cure Cancer’s Principal Supporter.
Zeyad was the Centre’s 12th FFCMH Post-doctoral Research Fellow (2016-2017) who went on to be awarded a NH&MRC Early Career Research Fellowship in 2018.
Zeyad’s funded research is “Targeting polyunsaturated fatty acid metabolism to overcome prostate cancer treatment resistance” . Cancer cells are characterized by uncontrolled cell proliferation, the ability to migrate and invade into other tissues, and resistance to treatment. These cellular capabilities require the production of additional energy by the cell. Prostate cancer cells rely mainly on lipids as fuel to supply the increasing demands on energy. Targeting the machinery (enzymes) that the cells use to break down lipids into energy may be a new way to slow tumor growth and metastasis. This research will go towards developing drugs that can target these lipid processing enzymes in prostate cancer.